|
|
(21 intermediate revisions by 2 users not shown) |
Property / publication date | |
| 25 July 2002Timestamp | +2002-07-25T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
| |
Property / publication date: 25 July 2002 / rank | |
| Normal rank
| |
Property / publication date: 25 July 2002 / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: 24-Ethyllathosterol / rank | |
| Normal rank
| |
Property / main subject: 24-Ethyllathosterol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: campesterol / rank | |
| Normal rank
| |
Property / main subject: campesterol / reference | |
| | |
Property / main subject | |
| 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| 10,13-dimethyl-17-(5-propan-2-ylhept-5-en-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 10,13-dimethyl-17-(5-propan-2-ylhept-5-en-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 10,13-dimethyl-17-(5-propan-2-ylhept-5-en-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: lathosterol / rank | |
| Normal rank
| |
Property / main subject: lathosterol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: avenasterol / rank | |
| Normal rank
| |
Property / main subject: avenasterol / reference | |
| | |
Property / main subject | |
| 9a,11a-dimethyl-1-(5,5,6-trimethylhept-6-en-2-yl)-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9bH,10H,11H-cyclopenta[a]phenanthren-7-ol | |
Property / main subject: 9a,11a-dimethyl-1-(5,5,6-trimethylhept-6-en-2-yl)-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9bH,10H,11H-cyclopenta[a]phenanthren-7-ol / rank | |
| Normal rank
| |
Property / main subject: 9a,11a-dimethyl-1-(5,5,6-trimethylhept-6-en-2-yl)-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9bH,10H,11H-cyclopenta[a]phenanthren-7-ol / reference | |
| | |
Property / main subject | |
| 17-(5,6-dimethylhept-6-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 17-(5,6-dimethylhept-6-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 17-(5,6-dimethylhept-6-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: Ergostan-3-ol, (3beta,5alpha)- / rank | |
| Normal rank
| |
Property / main subject: Ergostan-3-ol, (3beta,5alpha)- / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: 25-Methyl-24-methylenecholesterol / rank | |
| Normal rank
| |
Property / main subject: 25-Methyl-24-methylenecholesterol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: Cholesta-5,22-dien-3-ol,(3b,22E)- / rank | |
| Normal rank
| |
Property / main subject: Cholesta-5,22-dien-3-ol,(3b,22E)- / reference | |
| | |
Property / main subject | |
| 17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: Ergosta-5,24(28)-dien-3beta-ol / rank | |
| Normal rank
| |
Property / main subject: Ergosta-5,24(28)-dien-3beta-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: Stigmasta-5,25-dien-3-ol / rank | |
| Normal rank
| |
Property / main subject: Stigmasta-5,25-dien-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: (3beta,5alpha,24S)-Stigmasta-7,25-dien-3-ol / rank | |
| Normal rank
| |
Property / main subject: (3beta,5alpha,24S)-Stigmasta-7,25-dien-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: 24-α-ethylcholesterol / rank | |
| Normal rank
| |
Property / main subject: 24-α-ethylcholesterol / reference | |
| | |
Property / main subject | |
| 10,13-dimethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Property / main subject: 10,13-dimethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / rank | |
| Normal rank
| |
Property / main subject: 10,13-dimethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol / reference | |
| | |
Property / main subject | |
| | |
Property / main subject: 3-beta, 5-alpha-stigmastan-3-ol / rank | |
| Normal rank
| |
Property / main subject: 3-beta, 5-alpha-stigmastan-3-ol / reference | |
| | |
| Property / publication date |
| | January 1992Timestamp | +1992-01-00T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 month |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / publication date: January 1992 / rank |
| | Normal rank |
| Property / publication date: January 1992 / reference |
| | stated in: Crossref retrieved: 16 September 2022Timestamp | +2022-09-16T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|